Trial intelligence / Profile preview

DISCO VER continuation versus discontinuation of antiarrhythmic drugs before pulmonary vein isolation

NL-OMON42401Not yet recruiting

Sponsor: Medisch Spectrum Twente
Start: Oct 2015
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Randomised, open-label trial of adenosine in Atrial fibrillation (AFib) (2 arms), sponsored by Medisch Spectrum Twente. Primary endpoint: Incidence of dormant conduction after successful pulmonary vein isolation. Planned start Oct 2015; status: not yet recruiting.

Drugs

adenosine

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NL-OMON42401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42401.